@ARTICLE{
author={Knezevic-Ivanovski Tamara,Milic-Perovic Marija,Stopic Bojan,Golubovic Olga,Kralj Djordje,Mitrovic Milos,Sreckovic Slobodan,Dobrosavljevic Ana,Svorcan Petar V,Markovic Srdjan T},
year={2025},
title={Is Deep Remission the Right Time to De-Escalate Biologic Therapy in IBD? A Single-Center Retrospective Study},
journal={BIOMEDICINES},
volume={13},
number={8},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Colombel Jean Frederic,...,Sreckovic Slobodan,...,(broj koautora 33)},
year={2025},
title={Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY)},
journal={JOURNAL OF CROHNS & COLITIS},
volume={19},
number={6},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Hanauer Stephen B,...,Sreckovic Slobodan,...,(broj koautora 33)},
year={2024},
title={Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)},
journal={GASTROENTEROLOGY},
volume={167},
number={5},
pages={919-933},
document_type={Article; Proceedings Paper},
}